Lindonlight Collective

🌟 Celebrating Small Wins in the Fight Against Pediatric Brain Cancer 🌟 At Lindonlight Collective, every step forward is a reason to celebrate. Today, we're reflecting on the incredible progress we’ve made in raising awareness, funding innovative research, and supporting scientists in their pursuit of breakthroughs in pediatric brain cancer. Our mission remains clear: to give children and families fighting pediatric brain cancer better options and brighter futures. It’s the small wins, the moments of collaboration, and the passion from our team that keeps us motivated every day. What small win or moment of progress are you celebrating in your work? Let’s share our successes and continue to inspire one another! #PediatricBrainCancer #Impact #Progress #LindonlightCollective

🚨 THERE'S STILL TIME TO APPLY – SCIENTIFIC PROJECT PROPOSALS 🚨 The Lindonlight Collective is still accepting applications for our 2025–2026 Scientific Project Awards, offering up to $500,000 per project over a two-year award cycle. If you're working on groundbreaking research in pediatric brain cancer, don't miss this opportunity! 📅 Application Deadline: May 31, 2025 🚀 Project Start Date: July 1, 2025 💡 Want to strengthen your proposal? We encourage applicants to schedule a pre-meeting with our team to ensure alignment with our funding priorities and receive feedback on their planned submission. Email us at info@lindonlight.com to set up a time! Eligible applicants include tenure-track, clinical, and research faculty, instructors, classified scientists within academic research centers, federal intramural institutions, and biotech professionals. Multiple applications per institution are encouraged! 🔗 Learn more & apply: www.Lindonlight.com 📩 Questions? Contact us at info@lindonlight.com 📢 Help us spread the word! Tag a colleague or share this post—let’s fund bold ideas that will move the needle in pediatric brain cancer research. #LindonlightCollective #PediatricBrainCancer #ResearchFunding #ScientificInnovation #CallForProposals #CancerResearch

✨ Exciting News! ✨ Lindonlight Collective is proud to award a $500,000 grant to David H. Gutmann, MD, PhD, and Corina Anastasaki, PhD, at Washington University in St. Louis for their groundbreaking project: 🔬 Optimizing humanized preclinical low-grade glioma mouse models for immunologic targeting This research aims to enhance our understanding of low-grade gliomas and improve immunotherapeutic strategies—bringing us one step closer to better treatments for children with brain tumors. We are honored to support innovative science that drives real impact. Congratulations to Dr. Gutmann, Dr. Anastasaki, and their team on this important work! #LindonlightCollective #PediatricBrainCancer #CancerResearch #Glioma #FundingScience #pLGG #Collaboration #GroundbreakingScience

🌟 Employee Spotlight: Brittany Parker Kerrigan, COO of Lindonlight Collective 🌟 In celebration of Women's History Month, we're honored to spotlight our Chief Operating Officer, Brittany Parker Kerrigan, PhD, whose 15 years of experience in neuroscience cancer research have been instrumental in advancing our mission. With a deep-rooted passion for scientific innovation and a wealth of expertise, Brittany has seamlessly bridged the gap between research and operational excellence. Her strategic leadership has been instrumental in guiding Lindonlight Collective through complex challenges, ensuring that our projects not only thrive but also make a tangible impact. Brittany's commitment to fostering a collaborative and inclusive environment inspires us daily. Her journey serves as a powerful reminder of the impact that women in science and leadership can make. Join us in celebrating Brittany's remarkable contributions and all the incredible women making history in science! 👏 #WomensHistoryMonth #WomenInScience #Leadership #EmployeeSpotlight #PediatricBrainCancerResearch #LindonlightCollective

🌟 Employee Spotlight: Brittany Parker Kerrigan, COO of Lindonlight Collective 🌟 In celebration of Women's History Month, we're honored to spotlight our Chief Operating Officer, Brittany Parker Kerrigan, PhD, whose 15 years of experience in neuroscience cancer research have been instrumental in advancing our mission. With a deep-rooted passion for scientific innovation and a wealth of expertise, Brittany has seamlessly bridged the gap between research and operational excellence. Her strategic leadership has been instrumental in guiding Lindonlight Collective through complex challenges, ensuring that our projects not only thrive but also make a tangible impact. Brittany's commitment to fostering a collaborative and inclusive environment inspires us daily. Her journey serves as a powerful reminder of the impact that women in science and leadership can make. Join us in celebrating Brittany's remarkable contributions and all the incredible women making history in science! 👏 #WomensHistoryMonth #WomenInScience #Leadership #EmployeeSpotlight #PediatricBrainCancerResearch #LindonlightCollective

🌟 Happy International Women’s Day from Lindonlight Collective! 🌟 Today, we celebrate the remarkable achievements of women in science, leadership, and beyond. We are especially grateful for the talented and passionate women who drive innovation and impact within our team and across the pediatric brain cancer research community. Here's to the women leading with courage and vision—your contributions make the world brighter. 💖 ✨ #InternationalWomensDay #IWD2025 #WomenInScience #WomenInLeadership #EmbraceEquity #LindonlightCollective

👏 Happy Employee Appreciation Day! 👏 At Lindonlight Collective, our success is built on the dedication, passion, and hard work of our incredible team. Today, we want to take a moment to express our gratitude to each of you. Your commitment to advancing research and pushing boundaries inspires us every day. Whether you’re driving strategy, coordinating projects, or supporting our mission behind the scenes, your contributions are truly invaluable. Thank you for your expertise, enthusiasm, and for making Lindonlight a place where meaningful work happens. Here’s to our amazing team—today and every day! 🏆 #EmployeeAppreciationDay #TeamLindonlight #Gratitude #ResearchForACure #LindonlightCollective

🌟 Advancing Pediatric Brain Cancer Research 🌟 We are thrilled to announce that Lindonlight Collective has awarded $1,397,221 to Sachet Shukla, Ph.D., at The University of Texas MD Anderson Cancer Center to support IND-enabling studies for a personalized vaccine + T cell therapy for pediatric glioma patients. This innovative research represents a groundbreaking opportunity to bring much-needed progress to pediatric oncology. Dr. Shukla has demonstrated remarkable dedication—not only through his scientific expertise, but also through his willingness to seek out and thoughtfully incorporate feedback from leaders in the field. His commitment to refining this approach reflects a deep determination to ensure the success of this study. At Lindonlight, we believe in the power of collaboration. Beyond funding, we actively engage with Dr. Shukla’s team, leveraging our network and expertise to strengthen the foundation of this trial. We are excited to see the impact this work will have on children in need of better treatment options. 🔬 Together, we can drive innovation. Together, we can change lives. #PediatricCancer #GliomaResearch #Immunotherapy #CancerInnovation #Collaboration #LindonlightCollective #EndCancer #FundingResearch

🌟 Employee Spotlight: Dr. Ying Fu 🌟 We’re thrilled to highlight Dr. Ying Fu, Head of Biologics at Lindonlight Collective. With over 15 years of experience in biologics R&D, Ying has led groundbreaking work in ADCs and immunotherapy, driving innovation in pediatric low-grade gliomas (pLGG) and diffuse midline glioma (DMG). Before joining Lindonlight, Ying played a key role in developing multiple biologics at AstraZeneca and made pivotal discoveries at the NIH, where his work on GPC3-targeted ADCs and SARS-CoV-2 nanobodies gained global recognition. His expertise and leadership are advancing our mission to transform pediatric brain cancer treatment. #EmployeeSpotlight #Biologics #ADCs #CancerResearch #LindonlightCollective

Black History Month is not just a moment in time—it’s a continuous commitment to honoring the achievements, resilience, and contributions of Black individuals in science, medicine, and beyond. At Lindonlight Collective, we recognize that progress in pediatric brain cancer research is built on the dedication and brilliance of diverse minds. As we close out February, we reaffirm our commitment to fostering inclusivity, amplifying Black voices in STEM, and supporting equitable opportunities in research. Today and every day, we celebrate Black history, innovation, and impact. #BlackHistoryMonth #DiversityInSTEM #LindonlightCollective